V02.00 HepA/B vaccine (Temp) PGD amended to: 28 September 2018 include additional healthcare practitioners in Section 3 refer to vaccine incident guidelines in off-label and storage sections amended to reflect temporary recommendation updates and change in supply situation include minor rewording, layout and formatting changes for clarity and consistency with other PHE PGD templates PGD development This PGD has been developed by the following health professionals on behalf of Public Health England: Developed by: Name Signature Date Elizabeth Graham 28/09/2018 Pharmacist Lead Pharmacist - Immunisation (Lead Author) and Countermeasures, PHE Sema Mandal Doctor Consultant Epidemiologist, 28/09/2018 Immunisation and Countermeasures, PHE David Green 28/09/2018 Registered Nurse Consultant Immunisation – (Chair of Expert Panel) and Countermeasures, PHE This PGD has been peer reviewed by the PHE Immunisations PGD Expert in accordance with PHE PGD Policy. It has been ratified by the PHE Medicines Management Group and the PHE Quality and Clinical Governance Delivery Board. Expert Panel Name Designation Advanced Paramedic Practitioner/Emergency Care Practitioner, Ed Gardner Medicines Manager, Proactive Care Lead Jacqueline Lamberty Lead Pharmacist Medicines Management Services, Public Health England Vanessa MacGregor Consultant in Communicable Disease Control, Public Health England, East Midlands Health Protection Team Alison Mackenzie Consultant in Public Health Medicine / Screening and Immunisation Lead, Public Health England / NHS England South (South West) Sema Mandal Consultant Epidemiologist, Immunisation and Countermeasures, Public Health England Gill Marsh Senior Screening and Immunisation Manager, Public Health England / NHS England Lancashire and South Cumbria Lesley McFarlane Screening and Immunisation Co-ordinator, NHS England / Public Health England Leicestershire, Lincolnshire and Northamptonshire
V02.00 HepA/B vaccine (Temp) PGD amended to: include additional healthcare practitioners in Section 3 refer to vaccine incident guidelines in off-label and storage sections amended to reflect temporary recommendation updates and change in supply situation include minor rewording, layout and formatting changes for clarity and consistency with other PHE PGD templates 28 September 2018 PGD development This PGD has been developed by the following health professionals on behalf of Public Health England: Developed by: Name Signature Date Pharmacist (Lead Author) Elizabeth Graham Lead Pharmacist - Immunisation and Countermeasures, PHE 28/09/2018 Doctor Sema Mandal Consultant Epidemiologist, Immunisation and Countermeasures, PHE 28/09/2018 Registered (Chair of Expert Panel) David Green Nurse Consultant – Immunisation and Countermeasures, PHE 28/09/2018 This PGD has been peer reviewed by the PHE Immunisations PGD Expert in accordance with PHE PGD Policy. It has been ratified by the PHE Medicines Management Group and the PHE Quality and Clinical Governance Delivery Board. Expert Panel Name Designation Ed Gardner Advanced Paramedic Practitioner/Emergency Care Practitioner, Medicines Manager, Proactive Care Lead Jacqueline Lamberty Lead Pharmacist Medicines Management Services, Public Health England Vanessa MacGregor Consultant in Communicable Disease Control, Public Health England, East Midlands Health Protection Team Alison Mackenzie Consultant in Public Health Medicine / Screening and Immunisation Lead, Public Health England / NHS England South (South West) Sema Mandal Consultant Epidemiologist, Immunisation and Countermeasures, Public Health England Gill Marsh Senior Screening and Immunisation Manager, Public Health England / NHS England Lancashire and South Cumbria Lesley McFarlane Screening and Immunisation Co-ordinator, NHS England / Public Health England Leicestershire, Lincolnshire and Northamptonshire
20180928PHEPGDHepAandBTempv0200.docx